Overview
This month, we honor the vital contributions of our CT surgeons, whose dedication continues to drive innovation in lung cancer care and treatment. Through their collaboration, expertise, and shared commitment to progress, they've helped transform patient outcomes and elevate the field of thoracic surgery.
Explore how their ongoing efforts to advance surgical initiatives, support research, and embrace emerging technologies are making a profound impact on the specialty.
Podcasts
The "Thinking Thoracic" podcast series examines the latest advancements and breakthroughs in thoracic surgery.
Each episode is hosted by STS member surgeons and focuses on current news and trending topics within the specialty.
Insights Into the Landmark CheckMate 816 Trial
Host Erin Gillaspie, MD, sits down with Jonathan Spicer, MD, to discuss the landmark CheckMate 816 trial and its groundbreaking impact on immunotherapy, lung cancer treatment, and the future of thoracic surgery.
Rethinking Lung Cancer Screening Eligibility
Host Chi-Fu Jeffrey Yang, MD, joins Alexandra Potter to explore a recent study highlighting critical gaps in current lung cancer screening guidelines that leave nearly half of patients undetected.
General Thoracic Surgery Risk Calculators
STS's mobile-friendly risk calculators are designed to improve decision-making in thoracic surgery. These advanced tools were developed using contemporary data from the STS General Thoracic Surgery Database (GTSD).
Esophagectomy Risk Calculator
Allows surgeons and multidisciplinary medical providers to estimate a patient’s individualized risk in real-time for outcomes during esophageal cancer resection.
Lung Cancer Resection Risk Calculator
Provides individualized risk assessments based on specific patient factors, such as tumor characteristics, comorbidities, and the type of procedure performed.
Videos
The Surgeon’s Role in Managing Patients with Resectable NSCLC
In this video, thoracic surgeon Dr. Leah Backhus discusses the role of the multidisciplinary tumor board, a team-based approach to diagnosis and staging, and guiding patients through their treatment journey.
8 in 8: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC
This talk includes a look at the role of PD-L1 testing, peri-operative chemo-immunotherapy, and the importance of NGS testing for patients with actionable mutations.
8 in 8: Update on Immunotherapy for Resectable NSCLC
Dr. Jessica Donington provides the latest on adjuvant and neoadjuvant clinical trials that have recently concluded or will be releasing data in the near future.
Webinars
STS offers on-demand webinars on a variety of thoracic surgical topics.
Updates to the Treatment Landscape in NSCLC — Adjuvant and Neoadjuvant
This webinar reviews significant lung infections such as mucormycosis, tuberculosis, and hydatidosis. Our expert panel of speakers from...
Mobile Lung Cancer Screenings
This 30-minute session expands on the STS Roadmap to Mobile Lung Cancer Screenings and examines the intricacies of mobile cancer...
Appropriate Lung Cancer Staging and Diagnosis
A multidisciplinary approach to lung cancer staging and diagnosis from medical oncology, pulmonology, and cardiothoracic surgery...
Recent Articles and Research
Oligometastatic NSCLC: A Guideline for Surgical Management
Thoracic surgical oncologists developed evidence-based guidelines for pulmonary resection in oligometastatic NSCLC.
Breaking Barriers to Improve Lung Cancer Screening Rates
Despite evidence from the U.S. National Lung Screening Trial that low-dose CT screening reduces lung cancer mortality, only 16.5–18% of eligible individuals undergo screening.
Evaluation of Uncertain Resection for Localized Non-small Cell Lung Cancer
This study examined uncertain resection R(un) in localized non–small cell lung cancer, showing that inadequate lymph node assessment drives prognostic heterogeneity among R(un) patients.
Blogs
Sharing Inspiration for Lung Cancer Awareness Month
Dr. Shanda Blackmon explains what inspired her to become a thoracic surgeon and how low screening rates are leaving people at risk.
Lung Cancer Screenings and the Use of AI
Lung cancer is the deadliest cancer in the U.S. Early detection of lung cancer through low-dose computed tomography (LDCT) screening has...
New Frontiers in Lung Preservation
While expanding geographic boundaries will ultimately enable better organ and recipient matching, it poses inherent challenges to organ...
Advocacy
The Roadmap to Mobile Lung Cancer Screening
This online toolkit is designed for those who are interested in developing or expanding their institution’s lung cancer screening programs using mobile units.